In a report released today, Andy Hsieh from William Blair maintained a Buy rating on Skye Bioscience (SKYE – Research Report). The company’s ...

Fintel reports that on April 8, 2025, William Blair initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a ...

The original musical “Why Can’t They See?”, written by Pastor Bill Blair, will be presented at 7 p.m. on Maundy Thursday, ...

In a report released today, Jon Andersen from William Blair maintained a Buy rating on Simply Good Foods (SMPL – Research Report). The ...

Equities researchers at William Blair issued their Q2 2025 earnings per share (EPS) estimates for shares of Rekor Systems in a research report issued on Tuesday, April 1st. William Blair analyst L.

Stock analysts at William Blair lowered their Q2 2026 earnings per share estimates for shares of nCino in a report issued on Wednesday, April 2nd. William Blair analyst C. Kennedy now expects that the ...

Investment analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for shares of Rekor Systems in a research report issued to clients and investors on Tuesday, April 1st.

In a report released today, Matt Larew from William Blair maintained a Buy rating on 908 Devices (MASS – Research Report). The company’s shares opened today at $4.43. Discover outperforming ...

Fintel reports that on April 2, 2025, William Blair downgraded their outlook for nCino (NasdaqGS:NCNO) from Outperform to Market Perform. Analyst Price Forecast Suggests 85.69% Upside As of April ...

CEO Stephen Squeri said current strategy will continue, adding it would look to adjust expenses in areas such as marketing if ...